Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 10
Results: 37
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1883, doi. 10.1002/onco.13941
- By:
- Publication type:
- Article
Oncology Expanded Access and FDA's Project Facilitate.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1880, doi. 10.1002/onco.13910
- By:
- Publication type:
- Article
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early‐Onset Colorectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1730, doi. 10.1002/onco.13908
- By:
- Publication type:
- Article
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1704, doi. 10.1002/onco.13907
- By:
- Publication type:
- Article
One‐Step Polymerase Chain Reaction‐Free Nanowire‐Based Plasma Cell‐Free DNA Assay to Detect EML4‐ALK Fusion and to Monitor Resistance in Lung Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1683, doi. 10.1002/onco.13902
- By:
- Publication type:
- Article
Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 854, doi. 10.1002/onco.13901
- By:
- Publication type:
- Article
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1822, doi. 10.1002/onco.13900
- By:
- Publication type:
- Article
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011–2017.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1890, doi. 10.1002/onco.13898
- By:
- Publication type:
- Article
BRAF Inhibitor Therapy‐Related Encephalitis in a Patient with Metastatic Melanoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1887, doi. 10.1002/onco.13896
- By:
- Publication type:
- Article
A 10‐Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI‐CGA‐10) in Older Adults with Cancer: Development and Construct Validation.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1751, doi. 10.1002/onco.13894
- By:
- Publication type:
- Article
Long‐Term Survival of Combined Hepatocellular‐Cholangiocarcinoma: A Nationwide Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1774, doi. 10.1002/onco.13893
- By:
- Publication type:
- Article
A Cancer by Any Other Name.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 897, doi. 10.1002/onco.13891
- Publication type:
- Article
Province‐Wide Analysis of Patient‐Reported Outcomes for Stage IV Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1800, doi. 10.1002/onco.13890
- By:
- Publication type:
- Article
Plasma Cell‐Free DNA Genotyping: From an Emerging Concept to a Standard‐of‐Care Tool in Metastatic Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1812, doi. 10.1002/onco.13889
- By:
- Publication type:
- Article
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1870, doi. 10.1002/onco.13888
- By:
- Publication type:
- Article
Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1786, doi. 10.1002/onco.13887
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1895, doi. 10.1002/onco.13886
- By:
- Publication type:
- Article
Limited Impact of HER2 Expression on Survival Outcomes in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1893, doi. 10.1002/onco.13884
- By:
- Publication type:
- Article
Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 818, doi. 10.1002/onco.13880
- By:
- Publication type:
- Article
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1862, doi. 10.1002/onco.13879
- By:
- Publication type:
- Article
Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 827, doi. 10.1002/onco.13878
- By:
- Publication type:
- Article
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 845, doi. 10.1002/onco.13870
- By:
- Publication type:
- Article
Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1742, doi. 10.1002/onco.13868
- By:
- Publication type:
- Article
Artificial Intelligence in Cancer Care: Legal and Regulatory Dimensions.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 807, doi. 10.1002/onco.13862
- By:
- Publication type:
- Article
Impact of COVID‐19 Infection on Patients with Cancer: Experience in a Latin American Country: The ACHOCC‐19 Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1761, doi. 10.1002/onco.13861
- By:
- Publication type:
- Article
A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1844, doi. 10.1002/onco.13860
- By:
- Publication type:
- Article
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 879, doi. 10.1002/onco.13859
- By:
- Publication type:
- Article
Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 865, doi. 10.1002/onco.13858
- By:
- Publication type:
- Article
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857
- By:
- Publication type:
- Article
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 835, doi. 10.1002/onco.13855
- By:
- Publication type:
- Article
Phase II Study of 5‐Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX‐D) in First‐Line Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 825, doi. 10.1002/onco.13853
- By:
- Publication type:
- Article
Dexamethasone‐Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High‐Dose Cisplatin: A Randomized Noninferiority Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1854, doi. 10.1002/onco.13851
- By:
- Publication type:
- Article
Patient‐Reported Continuity of Care and Functional Safety Concerns After Inpatient Cancer Rehabilitation.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 887, doi. 10.1002/onco.13843
- By:
- Publication type:
- Article
Surgical Metastasectomy in the Spine: A Review Article.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1833, doi. 10.1002/onco.13840
- By:
- Publication type:
- Article
A Phase I Trial of Oxaliplatin, Irinotecan, and S‐1 Combination Therapy (OX‐IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403).
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1675, doi. 10.1002/onco.13838
- By:
- Publication type:
- Article
A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 811, doi. 10.1002/onco.13832
- By:
- Publication type:
- Article